Walgreens tackles declining profits, store closures, and rising costs. Learn about Sycamore Partners' acquisition offer of ...

Cencora, Inc. COR is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches.

Major indices skyrocketed on Wednesday as Donald Trump announced a 90-day pause to a number of his so-called "reciprocal" tariffs.

Adjusted earnings came in at $0.63 per share for the three-month period ended Feb. 28, exceeding analyst expectations of ...

Walgreens Boots Alliance reported stronger-than-expected second-quarter earnings Tuesday as the pharmacy chain accelerated ...

Pharmaceutical companies accused of fueling the nation's opioid crisis are paying state and local governments billions of ...

WBA's U.S. Retail Pharmacy segment had second quarter sales of $30.4 billion, an increase of 5.3% from the year-ago quarter.

The company is in the process of being taken private by Sycamore Partners in a deal that is expected to close in the fourth ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Edgewise Therapeutics (EWTX – Research Report), ...

AmerisourceBergen Corp is a pharmaceutical services company. It provides drug distribution and related healthcare services and solutions to pharmacy, physician, and manufacturer customers based in the ...

Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2025 on Wednesday, May 7, 2025, prior to the opening of trading on the New York Stock ...